Plasma Metabolite Profiles in Children with Current Asthma.

BACKGROUND

Identifying metabolomic profiles of children with asthma has the potential to increase understanding of asthma pathophysiology.

OBJECTIVE

To identify differences in plasma metabolites between children with and without current asthma at mid-childhood.

METHODS

We used untargeted mass spectrometry to measure plasma metabolites in 237 children (46 current asthma cases and 191 controls) in Project Viva, a birth cohort from eastern Massachusetts, USA. Current asthma was assessed at mid-childhood (mean age 8.0 years). The ability of a broad spectrum metabolic profile to distinguish between cases and controls was assessed using partial least squares discriminant analysis. We used logistic regression models to identify individual metabolites that were differentially abundant by case-control status. We tested significant metabolites for replication in 411 children from the VDAART clinical trial.

RESULTS

There was no evidence of a systematic difference in the metabolome of children reporting current asthma vs. healthy controls according to partial least squares discriminant analysis. However, several metabolites were associated with odds of current asthma at a nominally significant threshold (p<0.05), including a metabolite of nicotinamide (N1-Methyl-2-pyridone-5-carboxamide (Odds Ratio (OR)=2.8 (95% CI 1.1 to 8.0)), a pyrimidine metabolite (5,6-dihydrothymine (OR=0.4 (95% CI 0.2 to 0.9)), bile constituents (biliverdin (OR=0.4 (95%CI 0.1 to 0.9), taurocholate (OR=2.0 (95% CI 1.2 to 3.4)), two peptides likely derived from fibrinopeptide A (ORs from 1.6 to 1.7), and a gut microbiome metabolite (p-cresol sulfate OR=0.5 (95% CI 0.2 to 0.9)). The associations for N1-Methyl-2-pyridone-5-carboxamide and p-cresol sulfate replicated in the independent VDAART population(one-sided p values=0.03-0.04).

CONCLUSIONS AND CLINICAL RELEVANCE

Current asthma is nominally associated with altered levels of several metabolites, including metabolites in the nicotinamide pathway, and a bacterial metabolite derived from the gut microbiome. This article is protected by copyright. All rights reserved.

Abbreviation
Clin. Exp. Allergy
Publication Date
2018-05-28
Pubmed ID
29808611
Medium
Print-Electronic
Full Title
Plasma Metabolite Profiles in Children with Current Asthma.
Authors
Kelly RS, Sordillo JE, Lasky-Su J, Dahlin A, Perng W, Rifas-Shiman SL, Weiss ST, Gold DR, Litonjua AA, Hivert MF, Oken E, Wu AC